Provided by Tiger Fintech (Singapore) Pte. Ltd.

Aytu BioScience, Inc.

1.17
+0.09689.05%
Volume:36.43K
Turnover:41.96K
Market Cap:7.20M
PE:-0.61
High:1.21
Open:1.08
Low:1.07
Close:1.07
Loading ...

Aytu BioPharma to Present at the Planet MicroCap Showcase: VEGAS 2025 on April 23, 2025

ACCESS Newswire
·
22 Apr

Aytu BioPharma’s treatment of Marfan syndrome receives FDA orphan designation

TIPRANKS
·
15 Apr

Aytu BioPharma, Inc. (NASDAQ:AYTU) On The Verge Of Breaking Even

Simply Wall St.
·
08 Apr

Loss-Making Aytu BioPharma, Inc. (NASDAQ:AYTU) Set To Breakeven

Simply Wall St.
·
15 Feb

Aytu BioPharma Inc (AYTU) Q2 2025 Earnings Call Highlights: Strong Cash Position and Strategic ...

GuruFocus.com
·
13 Feb

Aytu Biopharma Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
13 Feb

Aytu BioPharma Q2 EPS $(0.28), Inline, Sales $16.22M Beat $15.55M Estimate

Benzinga
·
13 Feb

Aytu Biopharma Q2 Net Income USD 800 Thousand

THOMSON REUTERS
·
13 Feb

Aytu Biopharma Q2 Revenue USD 2.4 Million

THOMSON REUTERS
·
13 Feb

Aytu BioPharma Reports Fiscal 2025 Second Quarter Operational and Financial Results

ACCESS Newswire
·
13 Feb

Aytu BioPharma to Report Fiscal 2025 Second Quarter Operational and Financial Results on February 12, 2025

ACCESS Newswire
·
06 Feb

Aytu Biopharma Inc expected to post a loss of 28 cents a share - Earnings Preview

Reuters
·
03 Feb

Aytu BioPharma to Participate in the Lytham Partners 2025 Investor Healthcare Summit on January 13, 2025

ACCESSWIRE
·
06 Jan

Achieve Life Sciences Appoints Mark Oki CFO

MT Newswires Live
·
09 Dec 2024

Aytu BioPharma Proposes Settlement in Shareholder Lawsuit

TipRanks
·
05 Dec 2024

Aytu Biopharma Inc - Settlement Hearing Scheduled for January 13, 2025

THOMSON REUTERS
·
04 Dec 2024

Aytu BioPharma Disclosure Notification

ACCESSWIRE
·
04 Dec 2024

Aytu BioPharma Ranked as One of Fastest-Growing Companies in North America on the 2024 Deloitte Technology Fast 500(TM)

ACCESSWIRE
·
22 Nov 2024

Aytu BioPharma First Quarter 2025 Earnings: Beats Expectations

Simply Wall St.
·
16 Nov 2024

Aytu Biopharma Inc reports results for the quarter ended September 30 - Earnings Summary

Reuters
·
15 Nov 2024